126 related articles for article (PubMed ID: 29441453)
1. Prognostic significance of combining high mobility group Box-1 and OV-6 expression in hepatocellular carcinoma.
Zhu J; Yu H; Chen S; Yang P; Dong Z; Ling Y; Tang H; Bai S; Yang W; Tang L; Shen F; Wang H; Wen W
Sci China Life Sci; 2018 Aug; 61(8):912-923. PubMed ID: 29441453
[TBL] [Abstract][Full Text] [Related]
2. High-mobility group protein box1 expression correlates with peritumoral macrophage infiltration and unfavorable prognosis in patients with hepatocellular carcinoma and cirrhosis.
Zhang QB; Jia QA; Wang H; Hu CX; Sun D; Jiang RD; Zhang ZL
BMC Cancer; 2016 Nov; 16(1):880. PubMed ID: 27836008
[TBL] [Abstract][Full Text] [Related]
3. High expression of high mobility group box 1 (hmgb1) predicts poor prognosis for hepatocellular carcinoma after curative hepatectomy.
Liu F; Zhang Y; Peng Z; Gao H; Xu L; Chen M
J Transl Med; 2012 Jul; 10():135. PubMed ID: 22747650
[TBL] [Abstract][Full Text] [Related]
4. The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.
Zhang L; Han J; Wu H; Liang X; Zhang J; Li J; Xie L; Xie Y; Sheng X; Yu J
PLoS One; 2014; 9(10):e110626. PubMed ID: 25356587
[TBL] [Abstract][Full Text] [Related]
5. High‑mobility group box 1 has a prognostic role and contributes to epithelial mesenchymal transition in human hepatocellular carcinoma.
Liu Z; Dou C; Wang Y; Jia Y; Li Q; Zheng X; Yao Y; Liu Q; Song T
Mol Med Rep; 2015 Oct; 12(4):5997-6004. PubMed ID: 26252226
[TBL] [Abstract][Full Text] [Related]
6. Clinical Implication of the Relationship Between High Mobility Group Box-1 and Tumor Differentiation in Hepatocellular Carcinoma.
Ando K; Sakoda M; Ueno S; Hiwatashi K; Iino S; Minami K; Kawasaki Y; Hashiguchi M; Tanoue K; Mataki Y; Kurahara H; Maemura K; Shinchi H; Natsugoe S
Anticancer Res; 2018 Jun; 38(6):3411-3418. PubMed ID: 29848691
[TBL] [Abstract][Full Text] [Related]
7. Hepatitis B virus X protein stimulates high mobility group box 1 secretion and enhances hepatocellular carcinoma metastasis.
Chen S; Dong Z; Yang P; Wang X; Jin G; Yu H; Chen L; Li L; Tang L; Bai S; Yan H; Shen F; Cong W; Wen W; Wang H
Cancer Lett; 2017 May; 394():22-32. PubMed ID: 28216372
[TBL] [Abstract][Full Text] [Related]
8. OV6⁺ tumor-initiating cells contribute to tumor progression and invasion in human hepatocellular carcinoma.
Yang W; Wang C; Lin Y; Liu Q; Yu LX; Tang L; Yan HX; Fu J; Chen Y; Zhang HL; Tang L; Zheng LY; He YQ; Li YQ; Wu FQ; Zou SS; Li Z; Wu MC; Feng GS; Wang HY
J Hepatol; 2012 Sep; 57(3):613-20. PubMed ID: 22612999
[TBL] [Abstract][Full Text] [Related]
9. Methylation-mediated repression of microRNA-129-2 suppresses cell aggressiveness by inhibiting high mobility group box 1 in human hepatocellular carcinoma.
Liu Z; Dou C; Yao B; Xu M; Ding L; Wang Y; Jia Y; Li Q; Zhang H; Tu K; Song T; Liu Q
Oncotarget; 2016 Jun; 7(24):36909-36923. PubMed ID: 27191994
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of high mobility group box 1 with poor prognosis in patients after radical prostatectomy.
Li T; Gui Y; Yuan T; Liao G; Bian C; Jiang Q; Huang S; Liu B; Wu D
BJU Int; 2012 Dec; 110(11 Pt C):E1125-30. PubMed ID: 22672360
[TBL] [Abstract][Full Text] [Related]
11. Integration of OV6 expression and CD68
Wang MD; Xiang H; Zhang L; Wang C
Transl Oncol; 2022 Nov; 25():101509. PubMed ID: 36030750
[TBL] [Abstract][Full Text] [Related]
12. The association of HMGB1 gene with the prognosis of HCC.
Xiao J; Ding Y; Huang J; Li Q; Liu Y; Ni W; Zhang Y; Zhu Y; Chen L; Chen B
PLoS One; 2014; 9(2):e89097. PubMed ID: 24586525
[TBL] [Abstract][Full Text] [Related]
13. Potential role of High mobility group box 1 in hepatocellular carcinoma.
Zhou RR; Kuang XY; Huang Y; Li N; Zou MX; Tang DL; Fan XG
Cell Adh Migr; 2014; 8(5):493-8. PubMed ID: 25482616
[TBL] [Abstract][Full Text] [Related]
14. Combination of ULK1 and LC3B improve prognosis assessment of hepatocellular carcinoma.
Wu DH; Wang TT; Ruan DY; Li X; Chen ZH; Wen JY; Lin Q; Ma XK; Wu XY; Jia CC
Biomed Pharmacother; 2018 Jan; 97():195-202. PubMed ID: 29091866
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
[TBL] [Abstract][Full Text] [Related]
16. Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma.
Vilchez V; Turcios L; Zaytseva Y; Stewart R; Lee EY; Maynard E; Shah MB; Daily MF; Tzeng CW; Davenport D; Castellanos AL; Krohmer S; Hosein PJ; Evers BM; Gedaly R
Am J Surg; 2016 Aug; 212(2):238-45. PubMed ID: 27033253
[TBL] [Abstract][Full Text] [Related]
17. Low expression of B-cell-associated protein 31 in human primary hepatocellular carcinoma correlates with poor prognosis.
Tan N; Liu Q; Liu X; Gong Z; Zeng Y; Pan G; Xu Q; He S
Histopathology; 2016 Jan; 68(2):221-9. PubMed ID: 25980696
[TBL] [Abstract][Full Text] [Related]
18. MBD2 as a novel marker associated with poor survival of patients with hepatocellular carcinoma after hepatic resection.
Liu W; Wang N; Lu M; Du XJ; Xing BC
Mol Med Rep; 2016 Aug; 14(2):1617-23. PubMed ID: 27315121
[TBL] [Abstract][Full Text] [Related]
19. Proteomic profiling reveals the prognostic value of adenomatous polyposis coli-end-binding protein 1 in hepatocellular carcinoma.
Orimo T; Ojima H; Hiraoka N; Saito S; Kosuge T; Kakisaka T; Yokoo H; Nakanishi K; Kamiyama T; Todo S; Hirohashi S; Kondo T
Hepatology; 2008 Dec; 48(6):1851-63. PubMed ID: 18937283
[TBL] [Abstract][Full Text] [Related]
20. Tissue microarray-based study of hepatocellular carcinoma validating SPIB as potential clinical prognostic marker.
Ho YJ; Lin YM; Huang YC; Yeh KT; Lin LI; Lu JW
Acta Histochem; 2016 Jan; 118(1):38-45. PubMed ID: 26610895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]